I can offer them a few suggestions as to what they can do with all of the cosmetic info...
Let's face it, folks - Sculptra is one for the books - an official case study in how NOT to launch a product. Taking advantage of the HIV community to get your US indication just so that you can get out in front and sell a product stigmatized for "AIDS patients" off-label for cosmetic use? You've got to be kidding me. All the while with no promise (or hope for that matter) of ever having a cosmetic indication that would allow you to promote legitimately to cosmetic patients. It's a natural disaster of epic proportions! Oh, let's just lump on top of the heap the fact that it is difficult to use and can cause lumps in a patient's face if it's done incorrectly.
Now, Dermik did a fair bit of business on the hype of this product, but it was all sizzle and no steak. When the competitors in this space got a handle on Sculptra and launched their own products WITH a cosmetic indication, it was all over. Now it's time to close the books and move on. All of the reps who suffered setbacks to their careers have my pity. Unfortunately the filler business is now overflowing with reps thanks to the attrition rate at Dermik!
